These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 8942075)
21. The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. Lanier LL; Gumperz JE; Parham P; Melero I; López-Botet M; Phillips JH J Immunol; 1995 Apr; 154(7):3320-7. PubMed ID: 7897214 [TBL] [Abstract][Full Text] [Related]
22. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. Yawata M; Yawata N; Draghi M; Little AM; Partheniou F; Parham P J Exp Med; 2006 Mar; 203(3):633-45. PubMed ID: 16533882 [TBL] [Abstract][Full Text] [Related]
23. Host genetics and HIV--removing the mask. Michael NL Nat Med; 2002 Aug; 8(8):783-5. PubMed ID: 12152029 [No Abstract] [Full Text] [Related]
24. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. Chan HW; Kurago ZB; Stewart CA; Wilson MJ; Martin MP; Mace BE; Carrington M; Trowsdale J; Lutz CT J Exp Med; 2003 Jan; 197(2):245-55. PubMed ID: 12538663 [TBL] [Abstract][Full Text] [Related]
25. Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains. Rojo S; Wagtmann N; Long EO Eur J Immunol; 1997 Feb; 27(2):568-71. PubMed ID: 9045932 [TBL] [Abstract][Full Text] [Related]
26. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. Pando MJ; Gardiner CM; Gleimer M; McQueen KL; Parham P J Immunol; 2003 Dec; 171(12):6640-9. PubMed ID: 14662867 [TBL] [Abstract][Full Text] [Related]
27. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. Martin MP; Nelson G; Lee JH; Pellett F; Gao X; Wade J; Wilson MJ; Trowsdale J; Gladman D; Carrington M J Immunol; 2002 Sep; 169(6):2818-22. PubMed ID: 12218090 [TBL] [Abstract][Full Text] [Related]
28. High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles. Houtchens KA; Nichols RJ; Ladner MB; Boal HE; Sollars C; Geraghty DE; Davis LM; Parham P; Trachtenberg EA Immunogenetics; 2007 Jul; 59(7):525-37. PubMed ID: 17464504 [TBL] [Abstract][Full Text] [Related]
29. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. D'Andrea A; Chang C; Phillips JH; Lanier LL J Exp Med; 1996 Aug; 184(2):789-94. PubMed ID: 8760835 [TBL] [Abstract][Full Text] [Related]
30. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. Gardiner CM; Guethlein LA; Shilling HG; Pando M; Carr WH; Rajalingam R; Vilches C; Parham P J Immunol; 2001 Mar; 166(5):2992-3001. PubMed ID: 11207248 [TBL] [Abstract][Full Text] [Related]
31. Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses. Gaudieri S; Nolan D; McKinnon E; Witt CS; Mallal S; Christiansen FT Mol Immunol; 2005 Feb; 42(4):557-60. PubMed ID: 15607813 [TBL] [Abstract][Full Text] [Related]
32. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484 [TBL] [Abstract][Full Text] [Related]
33. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. Jennes W; Verheyden S; Demanet C; Adjé-Touré CA; Vuylsteke B; Nkengasong JN; Kestens L J Immunol; 2006 Nov; 177(10):6588-92. PubMed ID: 17082569 [TBL] [Abstract][Full Text] [Related]
34. Functional expression of the NKB1 killer cell inhibitory receptors on agammadelta CTL clone. Nakajima H; Moore YI; Takiguchi M Immunogenetics; 1997; 45(3):226-8. PubMed ID: 8995192 [No Abstract] [Full Text] [Related]
35. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation. McQueen KL; Dorighi KM; Guethlein LA; Wong R; Sanjanwala B; Parham P Hum Immunol; 2007 May; 68(5):309-23. PubMed ID: 17462498 [TBL] [Abstract][Full Text] [Related]
37. [Carrying certain KIR3DL1 alleles with HLA-B*57 is associated with protection from HIV infection]. Boulet S; Bernard NF Med Sci (Paris); 2008 Dec; 24(12):1030-2. PubMed ID: 19116110 [No Abstract] [Full Text] [Related]
38. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis. Díaz-Peña R; Vidal-Castiñeira JR; Alonso-Arias R; Suarez-Alvarez B; Vicario JL; Solana R; Collantes E; López-Vázquez A; Martínez-Borra J; López-Larrea C Arthritis Rheum; 2010 Apr; 62(4):1000-6. PubMed ID: 20131260 [TBL] [Abstract][Full Text] [Related]
39. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. Winter CC; Long EO J Immunol; 1997 May; 158(9):4026-8. PubMed ID: 9126959 [TBL] [Abstract][Full Text] [Related]
40. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis. Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]